Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01523509 · ClinicalTrials.gov registry record · Phase 1
Use of Radiographic Contrast to Detect Dental Caries
A Phase 1 study, sponsored by Creighton University.
- Completed
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
NCT01523509 is a Phase 1 study that has completed, run by Creighton University. The registered enrollment target is 33 participants.
The verdict
NCT01523509, a Phase 1 study, has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
Study Summary
The proposed test is intended to enable dentists to differentiate between cavitated and non-cavitated tooth decay in the areas where teeth are in contact (interproximal surfaces). In these areas, dentists cannot visually inspect for caries, and currently bitewing X-rays (BWs) only correctly detect the presence of enamel decay 15-25% of the time. This low sensitivity can lead to late treatment resulting in unnecessarily large fillings, crowns, pain, root canals, and possible later loss of teeth. Hypothesis: Use of radiographic contrast on teeth will increase the accuracy of detection of early cavitation from 58% to 90%.
Interventions
- DEVICE Radiographic contrast agent. Sodium Iodide.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01523509
The ClinicalTrials.gov registry entry for NCT01523509 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiographic contrast agent. Sodium Iodide. is the first listed.
NCT01523509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01523509 about?
NCT01523509 is a clinical study titled "Use of Radiographic Contrast to Detect Dental Caries". The proposed test is intended to enable dentists to differentiate between cavitated and non-cavitated tooth decay in the areas where teeth are in contact (interproximal surfaces). In these areas, dentists cannot visually inspect for caries, and currently bitewing X-rays (BWs) only correctly detect t...
What is the current status of trial NCT01523509?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2012-08. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01523509?
The interventions under investigation include: Radiographic contrast agent. Sodium Iodide. (DEVICE).
Who is sponsoring clinical trial NCT01523509?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.